Real World Experience of Ustekinumab for Induction and Maintenance of Remission in Crohn's Disease: A UK Single Center Experience

被引：0
|
作者：
Bhandare, Anirudh P. [1 ]
Crooks, Benjamin J. [2 ]
Taylor, J. [2 ]
Limdi, Jimmy K. [2 ]
机构：
[1] Northern Care Alliance, Manchester, Lancs, England
[2] Northern Care Alliance, Bury, England
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000592924.18268.27
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
847
引用
收藏
页码：S490 / S490
页数：1
相关论文
共 50 条
  • [41] Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center
    Zinger, Adar
    Choi, David K.
    Choi, Natalie K.
    Garcia, Nicole M.
    Cohen, Russell D.
    Dalal, Sushila
    Cleveland, Noa Krugliak
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S834 - S834
  • [42] Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission
    Shankar, Uday
    Vijayasekar, Kavitha
    Bansal, Raghav
    Walfish, Aaron
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : E3 - E3
  • [43] Methotrexate in the treatment of Crohn's disease: a Portuguese real-life single center experience
    Peixoto, A.
    Silva, M.
    Morais, R.
    Liberal, R.
    Lopes, S.
    Magro, F.
    Macedo, G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S194 - S195
  • [44] Endoscopic Response to Risankizumab in Patients With Refractory Crohn's Disease Who Failed Ustekinumab - Real-World Experience
    Patel, Parth B.
    Banerjee, Debdeep
    Norwood, Dalton A.
    Ismail, Mohamed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S851 - S851
  • [45] Use of ustekinumab in Crohn's disease: Singapore largest single-centre experience
    Shim, H. H.
    Kong, C.
    Ong, W. C.
    Lim, T. G.
    Chan, P. W.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S357 - S357
  • [46] P0832 Real-world effectiveness of risankizumab in Crohn's Disease: The UK Experience
    Elford, A.
    Plevris, N.
    Constantine-Cooke, N.
    Shah, K.
    Faloon, S.
    Colwill, M.
    Akbani, U.
    Morgan, H.
    Ghoda, A.
    Radia, C.
    Young, D.
    Morris, S.
    Anwar-Hashim, Z.
    Hassall, J.
    Thomas, M.
    Dyall, L.
    Clough, J.
    Mahmood, T.
    Mohammed, A.
    Rudling, R.
    Dhar, A.
    Gaya, D.
    Verma, A.
    Seenan, J.
    Johnston, E.
    Goel, R.
    Hicks, L.
    Sebastian, S.
    Hale, M.
    Harvey, P.
    Cooney, R.
    Cummings, F.
    Kent, A.
    King, A.
    Limdi, J.
    Sellinger, C.
    Pollok, R.
    Parkes, G.
    Lees, C.
    PAN UK Risankizumab CD Study Grp
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1589 - i1591
  • [47] A Multi-Center Study of the Outcomes of Risankizumab Use Stratified by Prior Ustekinumab Exposure in Patients With Crohn's Disease: A Real-World Experience
    Manski, Scott
    Andreone, Michael
    Swaminathan, Shreya
    Cordero-Baez, Fernando
    Sanchez, Jonathan Colon
    Kantor, Jenna
    Keith, Scott
    Shmidt, Eugenia
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S820 - S821
  • [48] Experience with Delayed-Release Mesalamine for Maintenance of Remission of Crohn's Disease (CD)
    Lichtenstein, Gary R.
    Ramsey, David
    GASTROENTEROLOGY, 2009, 136 (05) : A661 - A662
  • [49] Ustekinumab use in Crohn's disease: a tertiary centre experience
    Greenup, A.
    Rosenfeld, G.
    Bressler, B.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S384 - S385
  • [50] Ustekinumab Is Effective for the Induction and Maintenance of Response in Crohn's Disease: A Multi-center Cohort Study
    Ma, Christopher
    Fedorak, Richard
    Kaplan, Gilaad
    Dieleman, Levinus
    Kroeker, Karen
    Seow, Cynthia
    Leung, Yvette
    Novak, Kerri
    Halloran, Brendan
    Huang, Vivian
    Wong, Karen
    Devlin, Shane
    Ghosh, Subrata
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S294 - S294
12345